Medical Weight Loss for Muncie, Indiana Residents

Muncie, Indiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Muncie through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Start this week from Muncie: book a video visit, complete your intake, and if you are a fit, your compounded medication ships to your Indiana door. No travel to California required. Doctor review just $119 (medication separate).

Why Muncie Residents Choose New Hope Weight Loss

You never have to leave Muncie to work with us. The entire program runs by telehealth from our clinic in Costa Mesa, California, so your consultation, your follow-ups, and your dose adjustments all happen by video and message from wherever you are in Indiana. Whether you live near downtown Muncie, the university area, and the greater Delaware County area or further out, the care is identical. No commute, no waiting room, no rearranging your week around an appointment across town.

From our Costa Mesa, California practice, we provide Muncie with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.

The care you would find at our Costa Mesa clinic follows you home to Muncie through telehealth, giving Indiana patients the same physician oversight without a single mile of travel. We care for patients throughout downtown Muncie, the university area, and the greater Delaware County area. Your semaglutide or tirzepatide travels in insulated cold-pack packaging to keep it stable on the way to Muncie, even on warm Indiana afternoons.

There is no separate "out of town" rate, so Muncie and Indiana patients get the same program at the same price as everyone Dr. Sharma sees. Between Klarna, Affirm, and HSA or FSA cards, Muncie patients have several ways to handle the $119 review and ongoing medication payments. New Hope Weight Loss treats patients throughout Indiana entirely by telehealth from our Costa Mesa, California clinic, so the same physician care comes to you wherever you live in the state.

GLP-1 Weight Loss Programs Available

Compounded GLP-1 care, supervised by a physician

The 90-Day Metabolic Reset is built on semaglutide, the same active ingredient you will find in Wegovy and Ozempic. It is priced from $166/mo, with the complete 90-day program at $499, and branded-drug trials averaged about 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved, not brand-identical, and results vary by person. Dr. Sharma manages your care by telehealth, wherever you are in Muncie.

Prefer the dual-action route? Tirzepatide

From $233/mo, tirzepatide works on GLP-1 and GIP together. In branded-drug trials, dose-qualified patients reached up to 22.5 percent loss, a peak number that is not typical. Same active ingredient as Mounjaro and Zepbound.

It all starts with a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Muncie

Telehealth means your weight-loss care travels to you instead of the other way around. Patients across Muncie and the rest of start with a detailed online quiz covering medical history and goals. Dr. Anjmun Sharma personally reviews each intake and connects by secure video, usually inside 48 hours, to decide together whether a compounded GLP-1 is right. When she writes a prescription, the medication is filled by a state-licensed 503(a) pharmacy and mailed to your Muncie door in temperature-controlled cold-pack packaging. Ongoing follow-ups also happen by video, keeping your plan on track without a single in-person appointment.

Frequently Asked Questions, Muncie

How does someone in Muncie access New Hope Weight Loss?

Access from Muncie is entirely online. Our one physical clinic stands in Costa Mesa, California, while we serve Muncie, Indiana through telehealth. To begin, Dr. Anjmun Sharma meets you over secure video, reviews your background, and confirms whether you are eligible for a compounded GLP-1 program.

Is a clinic visit part of the process for Muncie residents?

A clinic visit is never part of it for Muncie. The model is fully telehealth, so your consult, refills, and check-ins happen from home. After Dr. Sharma approves you, medication is shipped to Muncie inside cold-pack packaging designed to maintain a steady temperature during transit.

What are the fees for Muncie patients?

The physician review costs $119. Compounded semaglutide runs from $166 each month, or $499 for the 90-day program, and tirzepatide from $233 each month. Medication is billed on its own. We honor HSA, FSA, Klarna, and Affirm, and Muncie residents are charged no distance surcharge.

What areas of Muncie do you serve?

We serve patients from across Muncie by telehealth, including downtown Muncie, the university area, and the greater Delaware County area.

What support is there for side effects for Muncie patients?

Dr. Sharma starts Muncie patients at a low dose and titrates slowly to limit nausea and GI effects, and your health advisor is reachable between visits by phone, WhatsApp, or message to adjust the plan if needed.

Muncie Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Muncie, Indiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.